Kilitch Drugs (India) has made additional investment of $2,00,000 to acquire equity shares of Kilitch Estro Biotech PLC, foreign subsidiary of the Company to enhance investment of Kilitch Drugs (India) for long term return of investment and to meet fund requirement of the subsidiary.
Kilitch Estro Biotech PLC is engaged in manufacturing of Pharmaceutical Products incorporated in September, 2015 in Ethiopia, commenced its production in January, 2022.
Kilitch Drugs (India) is an India-based company engaged in pharmaceutical business. The company’s services range from manufacturing to marketing a host of formulations in all dosage forms, such as solid, liquid and parenteral forms.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: